To OP.
Keep in mine that TM's do have clinical specialists that do a lot of the patient education and reprogrammings and case covered. It's a good gig, and rewarding. Find out what the territory your interested in revenue is and how many CS it has.
Even though everyone bashes STJ burst, and new primary cell's they are pushing. Even Boston Scientific will admit they've got a good product.
I don't work for any of the SCS companies. I did work for Medtronic DBS years ago and worked with Boston Scientific as a TM for a while.
I only left because I was tired of all the red tape with these Fortune 500 companies and now work for a small company (not neuromodulation) and enjoy not having the horse and pony show.
My personal opinion is:
Nevro: own trick pony, with their High frequency. Reps aren't hitting their crazy increased quota for a couple reasons. 1.) it's too high 2.) their explant rate has drastically increased recently. 3.) doctors are finally realizing that they new cool technology isn't all as good as it was when their SENZT RCT came out and they drank the koolaid from the Ex-Medtronic now Nevro Reps.
Medtronic: pushes is MRI portfolio. Until their new recent IPG that's current energy hit the market a couple months ago, their only development was the push for self adjusting STIM to patient position changes.
Been in the BIZ the longest, so doctors have solid relationships and think all the CS's they hire are giving them all this additional customer service TLC, when they really are just doing a massive amount of reprogrammings on patients that were implanted about 2 years ago that therapy isn't effective anymore.
Boston: well, what I witnessed was just preach their 4 ports, 32 contacts and MICC a with their 3D algorithm.
A little over a year ago, they finally had new technology and launched a full body conditional IPG and around the same time launched a single cell IPG. Which if the patient is using their 1k hz high frequency the single cell will drain in less than 6 months, requiring an IPG replacement. Unless they cycle the patient like every 20 minutes.
They have a new IPG that just launched.
It's their "multiple waveform" marketing pitch.
Which is just "me too" using STJ burst, Nevro's tingle free, and their own waveform that's called Prism which all they do is pull anodes or cathodes into the IPG.
STJ: good technology, in my geographic regional all the STJ TM's have solid relationships with the top # implanting docs in the area so they their market share by doc is less but by revenue is high. Still less than MDT, and more than Nevro and well Boston Scientific has hardly any market share recently.
Then their is Nuvectra: copied Boston Scientific's MICC technology and has 3 ports and 24 contacts. I personally their their steerable paddle lead is pretty cool. But majority of their business is from over dirt cheap prices on shit technology that hospital C-suite buys into to save money- most came from Boston and are just wasting the companies $ either sitting around on a non-compete or not honoring their non-compete and getting in some legal trouble.
Then their is the RF, which now Boston Scientific has bought their own RF company 6-8 months like St. Jude did a while back. But it doesn't matter because most customers want cooled RF therapy or are stuck in a contract with Stryker.
Not sure the 3rd thing you'll be selling like you mentioned. But all I can think of would be the DRG. I thought that STJ made that a different division though during the launch.
Also, DBS- MDT had no competition other then themselves until recently. St. Jude did get FDA approval over a year ago but hasn't been commercializing it like they should. And Boston has already hired a team of sales reps across the nation majority they stole from MDT, so when they get their FDA approval they can aggressively hit the ground running because by the time that happens all the MDT reps they took non-compete will be over
Overall- I would think this job is more rewarding then Ortho, but I don't know which niche of ortho you sell in.
Hope that helps. The money is better than 180K if you luck into a high revenue territory with a handful of high volume loyalists and the TM you're replacing didn't leave for a competitor.
But - sorry STJ reps- BURST does basically suck, even for you, MDT version and Boston version
